PTGS2 and colorectal carcinoma: DO analysis showed that 48 potential targets of HS were enriched in CRC, including PTGS2, DPP4, MAPK14, GSK3B, ACHE, CCND1, TNF, BAX, BCL2, CASP3, and CASP8 (Figure S1B).